It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs. The firm lowered its rating on MRNA to "neutral" from "buy," and nearly halved its price ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

Several of Donald Trump’s Cabinet picks, including Health and Human Services secretary nominee Robert F. Kennedy Jr., will face confirmation hearings today as the president continues to forge ahead ...